𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Riluzole Augmentation in Treatment-Resistant Obsessive–Compulsive Disorder: An Open-Label Trial

✍ Scribed by Vladimir Coric; Sarper Taskiran; Christopher Pittenger; Suzanne Wasylink; Daniel H. Mathalon; Gerald Valentine; John Saksa; Yu-te Wu; Ralitza Gueorguieva; Gerard Sanacora; Robert T. Malison; John H. Krystal


Book ID
119196840
Publisher
Elsevier Science
Year
2005
Tongue
English
Weight
132 KB
Volume
58
Category
Article
ISSN
0006-3223

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Amisulpiride augmentation in treatment r
✍ Özmen Metin; Kemal Yazici; Senel Tot; Aylin Ertekin Yazici 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB 👁 1 views

## Abstract Despite the effectiveness of clomipramine and selective serotonin reuptake inhibitors (SSRIs) in the treatment of obsessive–compulsive disorder (OCD), 40% to 60% of patients who receive an adequate treatment with these agents have significant persisting symptoms. Newer atypical antipsyc